Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults
Clinical trial NCT02788188 · COMPLETED
Trial details
- NCT number
- NCT02788188
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-28
- Primary completion
- 2018-04-10
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.